247 related articles for article (PubMed ID: 15180022)
1. Declining susceptibility to neomycin and polymyxin B of pathogens recovered in otitis externa clinical trials.
Cantrell HF; Lombardy EE; Duncanson FP; Katz E; Barone JS
South Med J; 2004 May; 97(5):465-71. PubMed ID: 15180022
[TBL] [Abstract][Full Text] [Related]
2. Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa.
Schwartz RH
Curr Med Res Opin; 2006 Sep; 22(9):1725-36. PubMed ID: 16968576
[TBL] [Abstract][Full Text] [Related]
3. Differences in bacteriologic treatment failures in acute otitis externa between ciprofloxacin/dexamethasone and neomycin/polymyxin B/hydrocortisone: results of a combined analysis.
Dohar JE; Roland P; Wall GM; McLean C; Stroman DW
Curr Med Res Opin; 2009 Feb; 25(2):287-91. PubMed ID: 19192973
[TBL] [Abstract][Full Text] [Related]
4. Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children.
Rahman A; Rizwan S; Waycaster C; Wall GM
Clin Ther; 2007 Sep; 29(9):1950-6. PubMed ID: 18035194
[TBL] [Abstract][Full Text] [Related]
5. Ofloxacin otic solution for treatment of otitis externa in children and adults.
Jones RN; Milazzo J; Seidlin M
Arch Otolaryngol Head Neck Surg; 1997 Nov; 123(11):1193-200. PubMed ID: 9366699
[TBL] [Abstract][Full Text] [Related]
6. Comparison of efficacy and safety of ciprofloxacin otic solution 0.2% versus polymyxin B-neomycin-hydrocortisone in the treatment of acute diffuse otitis externa*.
Drehobl M; Guerrero JL; Lacarte PR; Goldstein G; Mata FS; Luber S
Curr Med Res Opin; 2008 Dec; 24(12):3531-42. PubMed ID: 19032135
[TBL] [Abstract][Full Text] [Related]
7. In vitro evaluation of the synergistic activity of neomycin-polymyxin B association against pathogens responsible for otitis externa.
Tempera G; Mangiafico A; Genovese C; Giudice E; Mastrojeni S; Nicolosi D; Ferneri PM
Int J Immunopathol Pharmacol; 2009; 22(2):299-302. PubMed ID: 19505383
[TBL] [Abstract][Full Text] [Related]
8. Acute otitis externa: an update.
Schaefer P; Baugh RF
Am Fam Physician; 2012 Dec; 86(11):1055-61. PubMed ID: 23198673
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of ofloxacin otic solution once daily for 7 days in the treatment of otitis externa: a multicenter, open-label, phase III trial.
Torum B; Block SL; Avila H; Montiel F; Oliva A; Quintanilla W; Duncanson F; Cantrell HF; Riefler J; Katz E; Lombardy E
Clin Ther; 2004 Jul; 26(7):1046-54. PubMed ID: 15336469
[TBL] [Abstract][Full Text] [Related]
10. Microbiology of acute otitis externa.
Roland PS; Stroman DW
Laryngoscope; 2002 Jul; 112(7 Pt 1):1166-77. PubMed ID: 12169893
[TBL] [Abstract][Full Text] [Related]
11. Otitis externa: clinical comparison of local ciprofloxacin versus local oxytetracycline, polymyxin B, hydrocortisone combination treatment.
Arnes E; Dibb WL
Curr Med Res Opin; 1993; 13(3):182-6. PubMed ID: 8222746
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of topical ciprofloxacin/dexamethasone versus neomycin/polymyxin B/hydrocortisone for otitis externa.
Roland PS; Pien FD; Schultz CC; Henry DC; Conroy PJ; Wall GM; Garadi R; Dupre SJ; Potts SL; Hogg LG; Stroman DW;
Curr Med Res Opin; 2004 Aug; 20(8):1175-83. PubMed ID: 15324520
[TBL] [Abstract][Full Text] [Related]
13. A double-blind comparative study of ofloxacin otic drops versus neomycin-polymyxin B-hydrocortisone otic drops in the medical treatment of chronic suppurative otitis media.
Tong MC; Woo JK; van Hasselt CA
J Laryngol Otol; 1996 Apr; 110(4):309-14. PubMed ID: 8733449
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy and tolerability of two antibacterial/anti-inflammatory formulations ('Otomize' spray and 'Otosporin' drops) in the treatment of otitis externa in general practice.
Smith RB; Moodie J
Curr Med Res Opin; 1990; 11(10):661-7. PubMed ID: 2155756
[TBL] [Abstract][Full Text] [Related]
15. A single topical agent is clinically equivalent to the combination of topical and oral antibiotic treatment for otitis externa.
Roland PS; Belcher BP; Bettis R; Makabale RL; Conroy PJ; Wall GM; Dupre S; Potts S; Hogg G; Weber K;
Am J Otolaryngol; 2008; 29(4):255-61. PubMed ID: 18598837
[TBL] [Abstract][Full Text] [Related]
16. Ofloxacin otic drops vs neomycin-polymyxin B otic drops as prophylaxis against early postoperative tympanostomy tube otorrhea.
Poetker DM; Lindstrom DR; Patel NJ; Conley SF; Flanary VA; Link TR; Kerschner JE
Arch Otolaryngol Head Neck Surg; 2006 Dec; 132(12):1294-8. PubMed ID: 17178938
[TBL] [Abstract][Full Text] [Related]
17. [Ear drops otofa and polydexa for treatment of acute external otitis media in children].
Baliasinskaia GL
Vestn Otorinolaringol; 2003; (3):53-4. PubMed ID: 12847812
[No Abstract] [Full Text] [Related]
18. Controlled multicenter study on chronic suppurative otitis media treated with topical applications of ciprofloxacin 0.2% solution in single-dose containers or combination of polymyxin B, neomycin, and hydrocortisone suspension.
Miró N
Otolaryngol Head Neck Surg; 2000 Nov; 123(5):617-23. PubMed ID: 11077352
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of ofloxacin and other otic preparations for otitis externa.
Ruben RJ
Pediatr Infect Dis J; 2001 Jan; 20(1):108-10; discussion 120-2. PubMed ID: 11176588
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the treatment of otitis externa with 'Otosporin' and aluminium acetate: a report from a services practice in Cyprus.
Lambert IJ
J R Coll Gen Pract; 1981 May; 31(226):291-4. PubMed ID: 6273551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
